Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Camellia W. Adams0

Leonard G. Presta0

Mark Sliwkowski0

Date of Patent

March 3, 2009

0

Patent Application Number

112225870

Date Filed

September 9, 2005

0

Patent Citations Received

US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

0

US Patent 11654105 Subcutaneous HER2 antibody formulations

0

US Patent 11655305 Treatment of metastatic breast cancer

0

US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer

0

US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof

0

Patent Primary Examiner

Alana M. Harris

0

Patent abstract

The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and anti-hormonal compounds, such as anti-estrogens.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool